These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19403407)

  • 1. [Determination of the concentrations of interleukin-18 and other cytokines in the synovial fluid in patients with osteoarthritis].
    Li Y; Jiang JM; Yang DH; Wang FL; Mao ZX
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):729-31. PubMed ID: 19403407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentration of IL-18 and PGE2 in synovial fluid in patients with osteoarthritis and its significance].
    Peng CZ; Cao JM; Xiao T; Peng C; Yang HB; Chen X; Fang JZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):862-5. PubMed ID: 17213584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation.
    Futani H; Okayama A; Matsui K; Kashiwamura S; Sasaki T; Hada T; Nakanishi K; Tateishi H; Maruo S; Okamura H
    J Immunother; 2002; 25 Suppl 1():S61-4. PubMed ID: 12048352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamics of interleukin (IL)-18 in serum, synovial fluid and synovial membrane in the patients with rheumatoid arthritis].
    Munakata T; Uzuki M; Shimamura T; Sawai T
    Ryumachi; 2001 Jun; 41(3):625-34. PubMed ID: 11505512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of interleukin-1beta and tumor necrosis factor-alpha in the synovium and synovial fluid of patients with Kashin-Beck disease and osteoarthritis].
    Sun ZM; Ling M; Liu M; Zhang YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):5-8. PubMed ID: 19218098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.
    Kaneyama K; Segami N; Nishimura M; Suzuki T; Sato J
    Br J Oral Maxillofac Surg; 2002 Oct; 40(5):418-23. PubMed ID: 12379189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells.
    Doss F; Menard J; Hauschild M; Kreutzer HJ; Mittlmeier T; Müller-Steinhardt M; Müller B
    Scand J Rheumatol; 2007; 36(2):136-9. PubMed ID: 17476620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis.
    Honsawek S; Tanavalee A; Sakdinakiattikoon M; Chayanupatkul M; Yuktanandana P
    Clin Biochem; 2009 Jun; 42(9):808-12. PubMed ID: 19217889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
    LeGrand A; Fermor B; Fink C; Pisetsky DS; Weinberg JB; Vail TP; Guilak F
    Arthritis Rheum; 2001 Sep; 44(9):2078-83. PubMed ID: 11592370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: localization and role in the maturation of interleukin-1beta and interleukin-18.
    Saha N; Moldovan F; Tardif G; Pelletier JP; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1999 Aug; 42(8):1577-87. PubMed ID: 10446854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF.
    DeForge LE; Loyet KM; Delarosa D; Chinn J; Zamanian F; Chuntharapai A; Lee J; Hass P; Wei N; Townsend MJ; Wang J; Wong WL
    J Immunol Methods; 2010 Oct; 362(1-2):70-81. PubMed ID: 20833179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis.
    Gosset M; Berenbaum F; Salvat C; Sautet A; Pigenet A; Tahiri K; Jacques C
    Arthritis Rheum; 2008 May; 58(5):1399-409. PubMed ID: 18438860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
    Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
    Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expressions of interleukin 18 and prostaglandin E2 and their correlation in the synoviocytes of patients with osteoarthritis].
    Wang FL; Jiang JM; Wang F; Fu ZZ; Zhang ZF
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):731-3. PubMed ID: 20423837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.